Cargando…
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted,...
Autores principales: | Pothen, Lucie, Yildiz, Halil, Samnick, Mathilde Mbouck, Yombi, Jean Cyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810282/ https://www.ncbi.nlm.nih.gov/pubmed/33452660 http://dx.doi.org/10.1007/s10067-020-05572-9 |
Ejemplares similares
-
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center
por: Pothen, Lucie, et al.
Publicado: (2020) -
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020) -
Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
por: Nazir, Armaan M, et al.
Publicado: (2021) -
Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
por: Almoallim, Hani, et al.
Publicado: (2023) -
Moving towards online rheumatology education in the era of COVID-19
por: Ahmed, Sakir, et al.
Publicado: (2020)